A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting

导出原文传递

翻译打印收藏纠错

作者： Bao, Yun ^[1] ; Zhao, Gang ^[2] ; Qu, Shuli ^[3] ; Xiong, Tengbin ^[4] ; Yao, Xingxing ^[5] ; Wu, Bin

作者单位： Quintiles IMS, RWE Solut & HEOR, Shanghai, Peoples R China ^[1] Gansu Prov Hosp, Dept Pharm, Lanzhou, Gansu, Peoples R China ^[2] Sanofi China, HEOR, Shanghai, Peoples R China ^[3] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai, Peoples R China ^[4] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Med Decis & Econ Grp,Dept Pharm, South Campus ^[5]

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Clinical drug investigation

2020年40卷2期

161-171页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting

Clinical drug investigation

相似文献

Clinical drug investigation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting

Clinical drug investigation

相似文献

Clinical drug investigation

相关期刊

检索历史清除